{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:15:49Z","timestamp":1790874949073,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key R&D Project of Sichuan Provincial Department of Science and Technology","award":["2024YFFK0213"],"award-info":[{"award-number":["2024YFFK0213"]}]},{"name":"the Key R&D Project of Sichuan Provincial Department of Science and Technology","award":["2024YFFK0235"],"award-info":[{"award-number":["2024YFFK0235"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1245\/s10434-025-18810-8","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T15:21:30Z","timestamp":1765034490000},"page":"2114-2122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative Physiological Reserve and Pathological Response as Independent Predictors of Survival in Esophageal Squamous Cell Carcinoma after Neoadjuvant Therapy"],"prefix":"10.1245","volume":"33","author":[{"given":"Ruichen","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"18810_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074962","volume":"385","author":"N Deboever","year":"2024","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385:e074962.","journal-title":"BMJ"},{"key":"18810_CR2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404:1991\u20132005.","journal-title":"Lancet"},{"key":"18810_CR3","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3748\/wjg.v29.i30.4628","volume":"29","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana P, Leowattana T. Systemic treatments for resectable carcinoma of the esophagus. World J Gastroenterol. 2023;29:4628\u201341.","journal-title":"World J Gastroenterol"},{"key":"18810_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","volume":"34","author":"H Tang","year":"2023","unstructured":"Tang H, Wang H, Fang Y, Zhu JY, Yin J, Shen YX, Zeng ZC, Jiang DX, Hou YY, Du M, Lian CH. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial. Ann Oncol. 2023;34:163\u201372.","journal-title":"Ann Oncol"},{"key":"18810_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156:721\u20139.","journal-title":"JAMA Surg"},{"key":"18810_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamasurg.2021.2376","volume":"156","author":"XB Djourno","year":"2021","unstructured":"Djourno XB, Boulate D, Fourdrain A, et al. Risk prediction model of 90-day mortality after esophagectomy for cancer. JAMA Surg. 2021;156:836\u201345.","journal-title":"JAMA Surg"},{"key":"18810_CR7","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796\u2013803.","journal-title":"J Clin Oncol"},{"key":"18810_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2025.0220","volume":"160","author":"X Guo","year":"2025","unstructured":"Guo X, et al. Neoadjuvant chemoradiotherapy vs chemoimmunotherapy for esophageal squamous cell carcinoma. JAMA Surg. 2025;160:565\u201374.","journal-title":"JAMA Surg"},{"key":"18810_CR9","doi-asserted-by":"publisher","first-page":"947008","DOI":"10.3389\/fnut.2022.947008","volume":"9","author":"Y-M Gu","year":"2022","unstructured":"Gu Y-M, et al. The prognostic impact of preoperative body mass index changes for patients with esophageal squamous cell carcinoma who underwent esophagectomy: a large-scale long-term follow-up cohort study. Front Nutr. 2022;9:947008.","journal-title":"Front Nutr"},{"key":"18810_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12893-023-02149-6","volume":"23","author":"A Park","year":"2023","unstructured":"Park A, Orlandini MF, Szor DJ, Junior UR, Tustumi F. The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis. BMC Surg. 2023;23:240.","journal-title":"BMC Surg"},{"key":"18810_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ejso.2016.11.015","volume":"43","author":"M Paireder","year":"2017","unstructured":"Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2017;43:478\u201384.","journal-title":"Eur J Surg Oncol"},{"key":"18810_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.amjsurg.2020.02.035","volume":"220","author":"D Schizas","year":"2020","unstructured":"Schizas D, Giannopoulos S, Vailas M, et al. The impact of cirrhosis on esophageal cancer surgery: an up-to-date meta-analysis. Am J Surg. 2020;220:865\u201372.","journal-title":"Am J Surg"},{"key":"18810_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/jcsm.13462","volume":"15","author":"JY Jang","year":"2024","unstructured":"Jang JY, Oh D, Noh JM, et al. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy. J Cachexia Sarcopenia Muscle. 2024;15:1167\u201376.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"18810_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1245\/s10434-016-5610-8","volume":"24","author":"M Valmasoni","year":"2017","unstructured":"Valmasoni M, Pierobon ES, De Pasqual CA, et al. Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study. Ann Surg Oncol. 2017;24:763\u20139.","journal-title":"Ann Surg Oncol"},{"key":"18810_CR15","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1245\/s10434-014-3737-z","volume":"21","author":"S Ida","year":"2014","unstructured":"Ida S, Watanabe M, Karashima R, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675\u20139.","journal-title":"Ann Surg Oncol"},{"key":"18810_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266:822\u201330.","journal-title":"Ann Surg"},{"key":"18810_CR17","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.3390\/nu13114086","volume":"13","author":"JP Yoon","year":"2021","unstructured":"Yoon JP, Nam JS, Abidin MF, et al. Comparison of preoperative nutritional indexes for outcomes after primary esophageal surgery for esophageal squamous cell carcinoma. Nutrients. 2021;13:4086.","journal-title":"Nutrients"},{"key":"18810_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11605-012-2023-2","volume":"17","author":"M Scarpa","year":"2013","unstructured":"Scarpa M, Cagol M, Bettini S, et al. Overweight patients operated on for cancer of the esophagus survive longer than normal-weight patients. J Gastrointest Surg. 2013;17:218\u201327.","journal-title":"J Gastrointest Surg"},{"key":"18810_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7076","volume":"13","author":"CE Gaber","year":"2024","unstructured":"Gaber CE, Sarker J, Abdelaziz AI, et al. Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: a systematic review and meta-analysis. Cancer Med. 2024;13:e7076.","journal-title":"Cancer Med"},{"key":"18810_CR20","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1038\/bjc.2013.666","volume":"109","author":"SS Zhang","year":"2013","unstructured":"Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109:2894\u2013903.","journal-title":"Br J Cancer"},{"key":"18810_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Sharma R, Allara E, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66:338\u201346.","journal-title":"J Hepatol"},{"key":"18810_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103:725\u201334.","journal-title":"Br J Surg"},{"key":"18810_CR23","doi-asserted-by":"publisher","first-page":"100348","DOI":"10.1016\/j.esmoop.2021.100348","volume":"7","author":"K Takada","year":"2022","unstructured":"Takada K, Takamori S, Shimokawa M, et al. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2022;7:100348.","journal-title":"ESMO Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18810-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18810-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18810-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:39:45Z","timestamp":1770899985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18810-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["18810"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18810-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The work received funding from the Key R&D Project of Sichuan Provincial Department of Science and Technology (nos. 2024YFFK0235 and 2024YFFK0213). The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}